UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Delayed Administration of Sodium Thiosulfate in Animal Models Reduces Platinum Ototoxicity without Reduction of Antitumor Activity

Clinical cancer research, 2000-01, Vol.6 (1), p.309-315

2000

Volltextzugriff (PDF)

Phase I Study of Paclitaxel in Combination With a Multidrug Resistance Modulator, PSC 833 (Valspodar), in Refractory Malignancies

Journal of clinical oncology, 2000-03, Vol.18 (5), p.1124-1134

2000

Volltextzugriff (PDF)

Phase I Trial, Including Pharmacokinetic and Pharmacodynamic Correlations, of Combination Paclitaxel and Carboplatin in Patients With Metastatic Non–Small-Cell Lung Cancer

Journal of clinical oncology, 1999-02, Vol.17 (2), p.676-684

1999

Volltextzugriff (PDF)

Suramin, an Active Drug for Prostate Cancer: Interim Observations in a Phase I Trial

JNCI : Journal of the National Cancer Institute, 1993-04, Vol.85 (8), p.611-621

1993

Volltextzugriff (PDF)

Paclitaxel Disposition in Plasma and Central Nervous Systems of Humans and Rats With Brain Tumors

JNCI : Journal of the National Cancer Institute, 1995-07, Vol.87 (14), p.1077-1081

1995

Volltextzugriff (PDF)

Phase I study of weekly outpatient paclitaxel and concurrent cranial irradiation in adults with astrocytomas

Journal of clinical oncology, 1996-02, Vol.14 (2), p.600-609

1996

Volltextzugriff (PDF)

Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer

Journal of clinical oncology, 1995-09, Vol.13 (9), p.2174-2186

1995

Volltextzugriff (PDF)

A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer

Cancer chemotherapy and pharmacology, 1999, Vol.43 (2), p.106-114

1999

Volltextzugriff (PDF)

Development and validation of a pharmacokinetically based fixed dosing scheme for suramin

Journal of clinical oncology, 1995-09, Vol.13 (9), p.2187-2195

1995

Volltextzugriff (PDF)

Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma

Cancer chemotherapy and pharmacology, 2004-04, Vol.53 (4), p.329-336

2004

Volltextzugriff (PDF)

Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1

Cancer chemotherapy and pharmacology, 2001-04, Vol.47 (4), p.291-302

2001

Volltextzugriff (PDF)

Plasma pharmacokinetics and tissue distribution in CD2F1 mice of Pc4 (NSC 676418), a silicone phthalocyanine photodynamic sensitizing agent

Cancer chemotherapy and pharmacology, 1999, Vol.44 (4), p.283-294

1999

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of novobiocin in combination with VP-16 in patients with refractory malignancies

The cancer journal (Sudbury, Mass.), 2000-07, Vol.6 (4), p.256

2000

Volltextzugriff (PDF)

Suramin: development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancer

Journal of clinical oncology, 1994-01, Vol.12 (1), p.166-175

1994

Volltextzugriff (PDF)

Intraperitoneal gemcitabine therapy for advanced adenocarcinoma of the pancreas

Annals of surgical oncology, 2004-02, Vol.11 (S2), p.S55-S55

2004

Volltextzugriff (PDF)

Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance

Cancer research (Chicago, Ill.), 2003-01, Vol.63 (2), p.312-318

2003

Volltextzugriff (PDF)

Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunction

Cancer research (Chicago, Ill.), 1987-11, Vol.47 (22), p.6104-6110

1987

Volltextzugriff (PDF)

Approaches to optimal dosing of hexamethylene bisacetamide

Cancer chemotherapy and pharmacology, 1992-01, Vol.31 (1), p.37-45

1992

Volltextzugriff (PDF)

Phase I clinical and pharmacokinetic study of thiotepa administered intraperitoneally in patients with advanced malignancies

Journal of clinical oncology, 1989-01, Vol.7 (1), p.132-139

1989

Volltextzugriff (PDF)

Intravesical Gemcitabine Therapy for Superficial Transitional Cell Carcinoma of the Bladder: A Phase I and Pharmacokinetic Study

Journal of clinical oncology, 2003-02, Vol.21 (4), p.697-703

2003

Volltextzugriff (PDF)

Pharmacokinetics of Gemcitabine and 2′,2′‐Difluorodeoxyuridine in a Patient with Ascites

Pharmacotherapy, 2000-10, Vol.20 (10), p.1204-1207

2000

Volltextzugriff (PDF)

Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancer

Cancer chemotherapy and pharmacology, 1993, Vol.31 (5), p.363-368

1993

Volltextzugriff (PDF)

Phase I and pharmacokinetic trial of liposome-encapsulated doxorubicin

Cancer chemotherapy and pharmacology, 1993-03, Vol.33 (2), p.107-112

1993

Volltextzugriff (PDF)

Benzodiazepines compete for thyrotropin-releasing hormone receptor binding: Micromolar potency in rat pituitary, retina and amygdala

Neuroscience letters, 1983-11, Vol.41 (3), p.301-306

1983

Volltextzugriff (PDF)

Plasma pharmacokinetics and urinary excretion of hexamethylene bisacetamide metabolites

Cancer research (Chicago, Ill.), 1987-11, Vol.47 (22), p.6142-6146

1987

Volltextzugriff (PDF)

1 – 25 von 44

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(44)

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(33)
Science & Technology
(33)
Biological And Medical Sciences
(32)
Medical Sciences
(32)
Pharmacology. Drug Treatments
(31)
Humans
(29)
Oncology
(29)
Antineoplastic Agents
(27)
Chemotherapy
(20)
Male
(19)
Middle Aged
(18)
Female
(17)
Aged
(16)
Adult
(13)
Animals
(10)
Pharmacology & Pharmacy
(10)
Drug Administration Schedule
(9)
Chromatography, High Pressure Liquid
(7)
Infusions, Intravenous
(7)
Antineoplastic Agents - Pharmacokinetics
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Delayed Administration of Sodium Thiosulfate in Animal Models Reduces Platinum Ototoxicity without Reduction of Antitumor Activity

Phase I Study of Paclitaxel in Combination With a Multidrug Resistance Modulator, PSC 833 (Valspodar), in Refractory Malignancies

Phase I Trial, Including Pharmacokinetic and Pharmacodynamic Correlations, of Combination Paclitaxel and Carboplatin in Patients With Metastatic Non–Small-Cell Lung Cancer

Suramin, an Active Drug for Prostate Cancer: Interim Observations in a Phase I Trial

Paclitaxel Disposition in Plasma and Central Nervous Systems of Humans and Rats With Brain Tumors

Phase I study of weekly outpatient paclitaxel and concurrent cranial irradiation in adults with astrocytomas

Phase I and clinical evaluation of a pharmacologically guided regimen of suramin in patients with hormone-refractory prostate cancer

A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer

Development and validation of a pharmacokinetically based fixed dosing scheme for suramin

Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma

Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1

Plasma pharmacokinetics and tissue distribution in CD2F1 mice of Pc4 (NSC 676418), a silicone phthalocyanine photodynamic sensitizing agent

Phase I and pharmacokinetic study of novobiocin in combination with VP-16 in patients with refractory malignancies

Suramin: development of a population pharmacokinetic model and its use with intermittent short infusions to control plasma drug concentration in patients with prostate cancer

Intraperitoneal gemcitabine therapy for advanced adenocarcinoma of the pancreas

Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance

Phase I study and pharmacokinetics of menogaril (NSC 269148) in patients with hepatic dysfunction

Approaches to optimal dosing of hexamethylene bisacetamide

Phase I clinical and pharmacokinetic study of thiotepa administered intraperitoneally in patients with advanced malignancies

Intravesical Gemcitabine Therapy for Superficial Transitional Cell Carcinoma of the Bladder: A Phase I and Pharmacokinetic Study

Pharmacokinetics of Gemcitabine and 2′,2′‐Difluorodeoxyuridine in a Patient with Ascites

Phase II trial and pharmacokinetic assessment of intravenous melphalan in patients with advanced prostate cancer

Phase I and pharmacokinetic trial of liposome-encapsulated doxorubicin

Benzodiazepines compete for thyrotropin-releasing hormone receptor binding: Micromolar potency in rat pituitary, retina and amygdala

Plasma pharmacokinetics and urinary excretion of hexamethylene bisacetamide metabolites

Suchergebnisse filtern